Medical College of Wisconsin
CTSIResearch InformaticsREDCap

William See MD

Emeritus Professor

Institution: Medical College of Wisconsin
Department: Urology

Member of the Center for Disease Prevention Research (CDPR)

View Curriculum Vitae

Publications (154)

  • Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network. (Bukowy JD, Foss H, McGarry SD, Lowman AK, Hurrell SL, Iczkowski KA, Banerjee A, Bobholz SA, Barrington A, Dayton A, Unteriner J, Jacobsohn K, See WA, Nevalainen MT, Nencka AS, Ethridge T, Jarrard DF, LaViolette PS) J Med Imaging (Bellingham) 2020 Sep;7(5):057501 PMID: 33062803 PMCID: PMC7550797 SCOPUS ID: 2-s2.0-85096654686 10/17/2020       8 Citations
  • Factors Influencing Patient Selection of Urologists. (Berger GK, Medairos R, Regala P, Jacobsohn K, Langenstroer P, See WA, Johnson SC) Urology 2020 Mar;137:19-25 PMID: 31809771 SCOPUS ID: 2-s2.0-85077649742 12/07/2019       8 Citations
  • Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading. (Xin G, Khatun A, Topchyan P, Zander R, Volberding PJ, Chen Y, Shen J, Fu C, Jiang A, See WA, Cui W) Cancer Immunol Res 2020 Jan;8(1):7-18 PMID: 31719059 PMCID: PMC6946848 SCOPUS ID: 2-s2.0-85077667188 11/14/2019       20 Citations
  • Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. (Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT) Mol Cancer Ther 2020 Jan;19(1):231-246 PMID: 31548294 PMCID: PMC6946850 SCOPUS ID: 2-s2.0-85077669370 09/25/2019       21 Citations
  • Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 PMID: 31319388 SCOPUS ID: 2-s2.0-85070084884 07/19/2019       14 Citations
  • Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer. (Haddad BR, Erickson A, Udhane V, LaViolette PS, Rone JD, Kallajoki MA, See WA, Rannikko A, Mirtti T, Nevalainen MT) Cancer Epidemiol Biomarkers Prev 2019 Oct;28(10):1642-1651 PMID: 31292140 PMCID: PMC6774884 SCOPUS ID: 2-s2.0-85072849403 07/12/2019       10 Citations
  • Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space. (McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS) Tomography 2019 Mar;5(1):127-134 PMID: 30854450 PMCID: PMC6403022 SCOPUS ID: 2-s2.0-85071529534 03/12/2019       48 Citations
  • The implications of fellowship expansion on future pediatric urologist surgical volumes. (Groth TW, See WA, Ramsay S, Cooper CS, Kryger JV) J Pediatr Urol 2018 Jun;14(3):246-250 PMID: 29958643 SCOPUS ID: 2-s2.0-85047241816 07/01/2018       8 Citations
  • Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer. (McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS) Int J Radiat Oncol Biol Phys 2018 Aug 01;101(5):1179-1187 PMID: 29908785 PMCID: PMC6190585 SCOPUS ID: 2-s2.0-85048748761 06/18/2018       51 Citations
  • STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. (Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT) Clin Cancer Res 2018 Apr 15;24(8):1917-1931 PMID: 29483142 PMCID: PMC6036914 SCOPUS ID: 2-s2.0-85044579498 02/28/2018       51 Citations
  • Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. (Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS) J Med Imaging (Bellingham) 2018 Jan;5(1):011004 PMID: 29098169 PMCID: PMC5658575 SCOPUS ID: 2-s2.0-85032902519 11/04/2017       40 Citations
  • Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases. (Avallone MA, Sack BS, El-Arabi A, Charles DK, Herre WR, Radtke AC, Davis CM, See WA) J Endourol 2017 Aug;31(8):767-773 PMID: 28557554 PMCID: PMC5568593 SCOPUS ID: 2-s2.0-85027190863 05/31/2017       28 Citations
  • Toward Quantitative Whole Organ Thermoacoustics With a Clinical Array Plus One Very Low-Frequency Channel Applied to Prostate Cancer Imaging. (Patch SK, Hull D, See WA, Hanson GW) IEEE Trans Ultrason Ferroelectr Freq Control 2016 Feb;63(2):245-55 PMID: 26731749 PMCID: PMC4786189 SCOPUS ID: 2-s2.0-84962026543 01/06/2016       46 Citations
  • The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA) J Urol 2016 Jun;195(6):1903-10 PMID: 26694905 PMCID: PMC5796534 SCOPUS ID: 2-s2.0-84964576084 12/24/2015       13 Citations
  • Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion. (Jacobsohn K, Davis TD, El-Arabi AM, Tlachac J, Langenstroer P, O'Connor RC, Guralnick ML, See WA, Schlosser R) Can Urol Assoc J 2015;9(5-6):E367-71 PMID: 26225179 PMCID: PMC4479652 SCOPUS ID: 2-s2.0-84931826098 08/01/2015       2 Citations
  • Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. (Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L) Oncotarget 2015 Jun 30;6(18):16411-21 PMID: 25915538 PMCID: PMC4599278 SCOPUS ID: 2-s2.0-84937898954 04/29/2015       42 Citations
  • Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation. (Patch SK, Hull D, Thomas M, Griep SK, Jacobsohn K, See WA) Phys Med Biol 2015 Jan 21;60(2):689-708 PMID: 25554968 PMCID: PMC4292912 SCOPUS ID: 2-s2.0-84920836388 01/03/2015       18 Citations
  • Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2013; 112(5):561-7. doi:10.1111/bju.12216. [Epub 2013 Jul 2]. (See WA) Urol Oncol 2014 Nov;32(8):1350-1 PMID: 25488386 SCOPUS ID: 2-s2.0-84925843826 12/10/2014    
  • Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam Hospital, Amsterdam, The Netherlands.: BJU Int 2013; 112(6):72934. doi:10.1111/bju.12109. [Epub 2013 Jun 24]. (See WA) Urol Oncol 2014 Nov;32(8):1350 PMID: 25488385 SCOPUS ID: 2-s2.0-84925845003 12/10/2014    
  • Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332. (See WA) Urol Oncol 2014 Nov;32(8):1349-50 PMID: 25488384 SCOPUS ID: 2-s2.0-84929614757 12/10/2014    
  • Commentary on "Robot-assisted laparoscopic vs open radical cystectomy: Comparison of complications and perioperative oncological outcomes in 200 patients." Kader AK, Richards KA, Krane LS, Pettus JA, Smith JJ, Hemal AK, Division of Urology, UC San Diego Health System, San Diego, CA.: BJU Int 2013; 112(4):E290-4. doi:10.1111/bju.12167. [Epub 2013 Jul 1]. (See WA) Urol Oncol 2014 Nov;32(8):1348 PMID: 25488382 SCOPUS ID: 2-s2.0-84925857414 12/10/2014    
  • A comparison of case volumes among urologic surgeons identified on an industry-sponsored website to an all provider peer group. (See WA, Jacobson K, Derus S, Langenstroer P) Urol Oncol 2014 Nov;32(8):1095-100 PMID: 25260903 SCOPUS ID: 2-s2.0-84925879027 09/28/2014       2 Citations
  • Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. (Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN, Boardman L, Kohli M, Wang L) Eur Urol 2015 Jan;67(1):33-41 PMID: 25129854 PMCID: PMC4252606 SCOPUS ID: 2-s2.0-84924372715 08/19/2014       601 Citations
  • Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217). (Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S, Szczepanek C, Ryan A, Carlin S, Hill S, Goodman PJ, Padberg RM, Minasian LM, Meyskens FL, Thompson IM Jr) Cancer Epidemiol Biomarkers Prev 2014 Aug;23(8):1638-48 PMID: 25028457 PMCID: PMC4119542 SCOPUS ID: 2-s2.0-84905455445 07/17/2014       6 Citations
  • Senior medical student opinions regarding the ideal urology interview day. (Jacobs JC, Guralnick ML, Sandlow JI, Langenstroer P, Begun FP, See WA, O'Connor RC) J Surg Educ 2014;71(6):878-82 PMID: 24981655 SCOPUS ID: 2-s2.0-84920189952 07/02/2014       12 Citations
  • H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology. (Shah G, Zielonka J, Chen F, Zhang G, Cao Y, Kalyanaraman B, See W) J Urol 2014 Oct;192(4):1238-48 PMID: 24928267 PMCID: PMC5798233 SCOPUS ID: 2-s2.0-84921941445 06/15/2014       23 Citations
  • Immediate total parenteral nutrition after radical cystectomy and urinary diversion. (Pham KN, Schwartz LW, Garg T, Langenstroer P, Guralnick ML, See WA, O'Connor RC) WMJ 2014 Feb;113(1):20-3 PMID: 24712216 SCOPUS ID: 2-s2.0-84896696353 04/10/2014       6 Citations
  • Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer. (See WA) Eur Urol 2014 Jan;65(1):250 PMID: 24289855 SCOPUS ID: 2-s2.0-84888813359 12/03/2013    
  • V-Loc urethro-intestinal anastomosis during robotic cystectomy with orthotopic urinary diversion. (Pham KN, Sack BS, O'Connor RC, Guralnick ML, Langenstroer P, See WA, Jacobsohn K) Can Urol Assoc J 2013;7(11-12):E663-6 PMID: 24282453 PMCID: PMC3840523 SCOPUS ID: 2-s2.0-84887334572 11/28/2013       13 Citations
  • iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA) Urol Oncol 2014 Jan;32(1):45.e1-9 PMID: 24054867 PMCID: PMC5798243 SCOPUS ID: 2-s2.0-84890805014 09/24/2013       21 Citations
  • Loss of bacillus Calmette-Guérin viability adversely affects the direct response of urothelial carcinoma cells to bacillus Calmette-Guérin exposure. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See W) J Urol 2014 Mar;191(3):823-9 PMID: 24035882 PMCID: PMC5798236 SCOPUS ID: 2-s2.0-84893823729 09/17/2013       9 Citations
  • A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumes. (See WA) Urol Oncol 2014 Jan;32(1):42.e7-12 PMID: 23911685 SCOPUS ID: 2-s2.0-84890795894 08/06/2013       6 Citations
  • Commentary on "A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin." Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC: J Urol 2012;188(5):1712-8 [Epub 2012 Sep 19]. (See WA) Urol Oncol 2013 Jul;31(5):714 PMID: 23796197 SCOPUS ID: 2-s2.0-84879453920 06/26/2013    
  • Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]. (See WA) Urol Oncol 2013 Jul;31(5):716 PMID: 23796201 SCOPUS ID: 2-s2.0-84879444149 06/26/2013       1 Citation
  • Commentary on "Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?" Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands: J Urol 2012;188(4):1108-13 [Epub 2012 Aug 15]. (See WA) Urol Oncol 2013 Jul;31(5):716-7 PMID: 23796200 SCOPUS ID: 2-s2.0-84879456636 06/26/2013       2 Citations
  • Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]. (See WA) Urol Oncol 2013 Jul;31(5):715-6 PMID: 23796199 SCOPUS ID: 2-s2.0-84879453325 06/26/2013    
  • Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]. (See WA) Urol Oncol 2013 Jul;31(5):714-5 PMID: 23796198 SCOPUS ID: 2-s2.0-84879433514 06/26/2013    
  • Duloxetine for the treatment of post-prostatectomy stress urinary incontinence. (Neff D, Guise A, Guralnick ML, Langenstroer P, See WA, Jacobsohn KM, O'Connor RC) Can Urol Assoc J 2013;7(5-6):E260-2 PMID: 23766826 PMCID: PMC3668403 SCOPUS ID: 2-s2.0-84877829967 06/15/2013       16 Citations
  • Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin. (Zhang G, Chen F, Cao Y, See WA) J Urol 2013 Oct;190(4):1398-403 PMID: 23583857 SCOPUS ID: 2-s2.0-84883773485 04/16/2013       8 Citations
  • HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin. (Zhang G, Chen F, Cao Y, Amos JV, Shah G, See WA) J Urol 2013 Sep;190(3):1076-82 PMID: 23353043 SCOPUS ID: 2-s2.0-84881480834 01/29/2013       17 Citations
  • Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC-tandem mass spectrometry. (Chen W, Wang D, Wang LS, Bei D, Wang J, See WA, Mallery SR, Stoner GD, Liu Z) J Chromatogr B Analyt Technol Biomed Life Sci 2012 Nov 01;908:39-44 PMID: 23122399 PMCID: PMC3538353 SCOPUS ID: 2-s2.0-84867456967 11/06/2012       44 Citations
  • HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin. (Zhang G, Chen F, Cao Y, Johnson B, See WA) J Urol 2013 Apr;189(4):1541-6 PMID: 23041342 SCOPUS ID: 2-s2.0-84875940317 10/09/2012       7 Citations
  • A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin. (Chen F, Zhang G, Cao Y, Wakim B, See WA) J Urol 2013 Mar;189(3):1104-9 PMID: 22999999 SCOPUS ID: 2-s2.0-84873725495 09/25/2012       4 Citations
  • Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. (See WA) Eur Urol 2012 May;61(5):1066 PMID: 22469416 SCOPUS ID: 2-s2.0-84859335258 04/04/2012    
  • Specific heat capacity of freshly excised prostate specimens. (Patch SK, Rao N, Kelly H, Jacobsohn K, See WA) Physiol Meas 2011 Nov;32(11):N55-64 PMID: 22027030 SCOPUS ID: 2-s2.0-80055052509 10/27/2011       10 Citations
  • The association of robotic surgical technology and hospital prostatectomy volumes: increasing market share through the adoption of technology. (Neuner JM, See WA, Pezzin LE, Tarima S, Nattinger AB) Cancer 2012 Jan 15;118(2):371-7 PMID: 21717434 SCOPUS ID: 2-s2.0-84855483445 07/01/2011       40 Citations
  • Ex vivo thermoacoustic imaging over large fields of view with 108 MHz irradiation. (Eckhart AT, Balmer RT, See WA, Patch SK) IEEE Trans Biomed Eng 2011 Aug;58(8) PMID: 21421431 SCOPUS ID: 2-s2.0-79960743244 03/23/2011       41 Citations
  • Assessment and management of irritative voiding symptoms. (Guralnick ML, O'Connor RC, See WA) Med Clin North Am 2011 Jan;95(1):121-7 PMID: 21095416 SCOPUS ID: 2-s2.0-78649357776 11/26/2010       5 Citations
  • Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372. (See WA) J Urol 2010 Oct;184(4):1573-4; author reply 1574 PMID: 20732691 SCOPUS ID: 2-s2.0-84755161825 08/25/2010    
  • Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach. (Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, Wakim BT) J Urol 2010 Aug;184(2):709-14 PMID: 20639044 SCOPUS ID: 2-s2.0-77955466696 07/20/2010       33 Citations
  • Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. (Iversen P, McLeod DG, See WA, Morris T, Armstrong J, Wirth MP, Casodex Early Prostate Cancer Trialists' Group) BJU Int 2010 Apr;105(8):1074-81 PMID: 22129214 SCOPUS ID: 2-s2.0-77950217230 04/01/2010       98 Citations
  • MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. (Chen F, Zhang G, Cao Y, Hessner MJ, See WA) J Urol 2009 Dec;182(6):2932-7 PMID: 19853870 SCOPUS ID: 2-s2.0-72149092392 10/27/2009       25 Citations
  • Laparoscopic mesh herniorrhaphy: impact on outcomes associated with radical retropubic prostatectomy. (Neff DA, See WA) Urol Oncol 2011;29(1):66-9 PMID: 19837615 SCOPUS ID: 2-s2.0-78650677465 10/20/2009       6 Citations
  • Resonance metallic ureteral stents do not successfully treat ureteroenteric strictures. (Garg T, Guralnick ML, Langenstroer P, See WA, Hieb RA, Rilling WS, Sudakoff GS, O'Connor RC) J Endourol 2009 Jul;23(7):1199-201; discussion 1202 PMID: 19530950 SCOPUS ID: 2-s2.0-67650783484 06/18/2009       32 Citations
  • p21 Expression by human urothelial carcinoma cells modulates the phenotypic response to BCG. (See WA, Zhang G, Chen F, Cao Y) Urol Oncol 2010;28(5):526-33 PMID: 19450997 SCOPUS ID: 2-s2.0-77956284009 05/20/2009       12 Citations
  • Bladder neck contracture after radical retropubic prostatectomy using an intussuscepted vesico-urethral anastomosis: incidence with long-term follow-up. (Garg T, See WA) BJU Int 2009 Oct;104(7):925-8 PMID: 19389011 SCOPUS ID: 2-s2.0-70049106243 04/25/2009       12 Citations
  • Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1. (See WA, Zhang G, Chen F, Cao Y, Langenstroer P, Sandlow J) BJU Int 2009 Jun;103(12):1714-20 PMID: 19154459 SCOPUS ID: 2-s2.0-67149128203 01/22/2009       40 Citations
  • SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. (Zhi H, Yang XJ, Kuhnmuench J, Berg T, Thill R, Yang H, See WA, Becker CG, Williams CL, Li R) J Pathol 2009 Feb;217(3):389-97 PMID: 18973191 SCOPUS ID: 2-s2.0-60549096862 11/01/2008       22 Citations
  • Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. (Sudakoff GS, Dunn DP, Guralnick ML, Hellman RS, Eastwood D, See WA) J Urol 2008 Mar;179(3):862-7; discussion 867 PMID: 18221955 SCOPUS ID: 2-s2.0-39149098795 01/29/2008       88 Citations
  • Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury. (Chen F, Zhang G, Cao Y, Payne R, See WA) J Urol 2007 Nov;178(5):2166-70 PMID: 17870116 SCOPUS ID: 2-s2.0-35148865562 09/18/2007       12 Citations
  • Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway. (Zhang G, Chen F, Cao Y, See WA) Urol Oncol 2007;25(3):221-7 PMID: 17483019 SCOPUS ID: 2-s2.0-34247582392 05/08/2007       10 Citations
  • Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. (Smither AR, Guralnick ML, Davis NB, See WA) BMC Urol 2007 Feb 05;7:2 PMID: 17280607 PMCID: PMC1800860 SCOPUS ID: 2-s2.0-33847060767 02/07/2007       73 Citations
  • Bicalutamide adjuvant to radical prostatectomy. (See WA) Rev Urol 2004;6 Suppl 2(Suppl 2):S20-8 PMID: 16985857 PMCID: PMC1472855 09/21/2006    
  • The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer. (See WA, Tyrrell CJ, CASODEX Early Prostate Cancer Trialists' Group) J Cancer Res Clin Oncol 2006 Aug;132 Suppl 1(Suppl 1):S7-16 PMID: 16896884 PMCID: PMC12161113 SCOPUS ID: 2-s2.0-33846456924 08/10/2006       57 Citations
  • The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup. (McLeod DG, See WA, Klimberg I, Gleason D, Chodak G, Montie J, Bernstein G, Morris C, Armstrong J) J Urol 2006 Jul;176(1):75-80 PMID: 16753373 SCOPUS ID: 2-s2.0-33744810580 06/07/2006       41 Citations
  • Are bone scans necessary in men with low prostate specific antigen levels following localized therapy? (Warren KS, Chodak GW, See WA, Iverson P, McLeod D, Wirth M, Morris C, Armstrong J) J Urol 2006 Jul;176(1):70-3; discussion 73-4 PMID: 16753371 SCOPUS ID: 2-s2.0-33744785366 06/07/2006       12 Citations
  • Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. (Lawatsch EJ, Langenstroer P, Byrd GF, See WA, Quiroz FA, Begun FP) J Urol 2006 Apr;175(4):1225-9; discussion 1229 PMID: 16515964 SCOPUS ID: 2-s2.0-33644602293 03/07/2006       55 Citations
  • Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. (McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP, Casodex Early Prostate Cancer Trialists' Group) BJU Int 2006 Feb;97(2):247-54 PMID: 16430622 SCOPUS ID: 2-s2.0-33644857333 01/25/2006       256 Citations
  • Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma. (Zhang G, Cao Y, Xu Y, See WA) Urol Oncol 2005;23(6):413-8 PMID: 16301119 SCOPUS ID: 2-s2.0-27844451472 11/23/2005       1 Citation
  • Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme. (Tyrrell CJ, Payne H, See WA, McLeod DG, Wirth MP, Iversen P, Armstrong J, Morris C, 'Casodex' Early Prostate Cancer Trialists Group) Radiother Oncol 2005 Jul;76(1):4-10 PMID: 16145740 SCOPUS ID: 2-s2.0-23244464659 09/08/2005       62 Citations
  • BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking. (Chen F, Zhang G, Iwamoto Y, See WA) BMC Urol 2005 May 12;5:8 PMID: 15890073 PMCID: PMC1174876 SCOPUS ID: 2-s2.0-23044445886 05/14/2005       51 Citations
  • Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. (Nithipatikom K, Isbell MA, See WA, Campbell WB) Cancer Lett 2006 Feb 28;233(2):219-25 PMID: 15882928 SCOPUS ID: 2-s2.0-33644648950 05/11/2005       44 Citations
  • CT urography of urinary diversions with enhanced CT digital radiography: preliminary experience. (Sudakoff GS, Guralnick M, Langenstroer P, Foley WD, Cihlar KL, Shakespear JS, See WA) AJR Am J Roentgenol 2005 Jan;184(1):131-8 PMID: 15615963 SCOPUS ID: 2-s2.0-11144271119 12/24/2004       40 Citations
  • Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. (Wirth MP, See WA, McLeod DG, Iversen P, Morris T, Carroll K, Casodex Early Prostate Cancer Trialists' Group) J Urol 2004 Nov;172(5 Pt 1):1865-70 PMID: 15540740 SCOPUS ID: 2-s2.0-5444248630 11/16/2004       201 Citations
  • Autocrine over expression of fibronectin by human transitional carcinoma cells impairs bacillus Calmette-Guerin adherence and signaling. (Zhang G, Chen F, Xu Y, Cao Y, Crist S, McKerrow A, Iwamoto Y, See WA) J Urol 2004 Oct;172(4 Pt 1):1496-500 PMID: 15371878 SCOPUS ID: 2-s2.0-4544309705 09/17/2004       4 Citations
  • Positron emission tomography-computed tomography imaging characteristics of an inferior vena cava tumor thrombus with magnetic resonance imaging correlation. (Rydberg JN, Sudakoff GS, Hellman RS, See WA) J Comput Assist Tomogr 2004;28(4):517-9 PMID: 15232383 SCOPUS ID: 2-s2.0-3342926034 07/03/2004       5 Citations
  • Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program. (Iversen P, Wirth MP, See WA, McLeod DG, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Lundmo P, Tammela TL, Johansson JE, Morris T, Carroll K, Casodex Early Prostate Cancer Trialists' Group) Urology 2004 May;63(5):928-33 PMID: 15134983 SCOPUS ID: 2-s2.0-2342521342 05/12/2004       16 Citations
  • Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium. (Dreicer R, Manola J, Roth BJ, See WA, Kuross S, Edelman MJ, Hudes GR, Wilding G) Cancer 2004 Apr 15;100(8):1639-45 PMID: 15073851 SCOPUS ID: 2-s2.0-1842477465 04/10/2004       176 Citations
  • Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. (Chen F, Langenstroer P, Zhang G, Iwamoto Y, See W) J Urol 2003 Nov;170(5):2009-13 PMID: 14532843 SCOPUS ID: 2-s2.0-0141885265 10/09/2003       45 Citations
  • Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer. (See WA) Curr Treat Options Oncol 2003 Oct;4(5):351-62 PMID: 12941195 SCOPUS ID: 2-s2.0-0142244519 08/28/2003       6 Citations
  • Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin. (Chen F, Zhang G, Iwamoto Y, See WA) J Urol 2003 Aug;170(2 Pt 1):605-10 PMID: 12853840 SCOPUS ID: 2-s2.0-0037830769 07/11/2003       23 Citations
  • Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. (See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ, Casodex Early Prostate Cancer Trialist Group) J Urol 2002 Aug;168(2):429-35 PMID: 12131282 SCOPUS ID: 2-s2.0-0036071805 07/20/2002       214 Citations
  • Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway. (Chen FH, Crist SA, Zhang GJ, Iwamoto Y, See WA) J Urol 2002 Aug;168(2):786-97 PMID: 12131369 SCOPUS ID: 2-s2.0-0036074780 07/20/2002       38 Citations
  • Phase II trial of GM-CSF in advanced prostate cancer. (Dreicer R, See WA, Klein EA) Invest New Drugs 2001;19(3):261-5 PMID: 11561685 SCOPUS ID: 2-s2.0-0034856873 09/20/2001       35 Citations
  • Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. (Siemens DR, Austin JC, See WA, Tartaglia J, Ratliff TL) J Urol 2001 Feb;165(2):667-71 PMID: 11176455 SCOPUS ID: 2-s2.0-0035176446 02/15/2001       21 Citations
  • The bicalutamide Early Prostate Cancer Program. Demography. (See WA, McLeod D, Iversen P, Wirth M) Urol Oncol 2001 Mar;6(2):43-47 PMID: 11166619 02/13/2001    
  • Autocrine IL-6 production by human transitional carcinoma cells upregulates expression of the alpha5beta1 firbonectin receptor. (Zhang GJ, Crist SA, McKerrow AK, Xu Y, Ladehoff DC, See WA) J Urol 2000 May;163(5):1553-9 PMID: 10751887 SCOPUS ID: 2-s2.0-0034005953 02/07/2001       28 Citations
  • Biomarker distribution after injection into the canine prostate: implications for gene therapy. (Siemens DR, Iwasawa T, Austin JC, Williams RD, See WA, Hedican SP, Tartaglia J, Flynn CM, Cohen MB, Rodgers J, Ratliff TL) BJU Int 2000 Dec;86(9):1076-83 PMID: 11119105 SCOPUS ID: 2-s2.0-0034537094 12/19/2000       4 Citations
  • Their initial experience with laparoscopy-assisted cystectomy. (Zayyan KS, See WA) World J Surg 2000 Oct;24(10):1282-3 PMID: 11071477 SCOPUS ID: 2-s2.0-0034302918 11/09/2000       1 Citation
  • Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignancies. (See WA) Urology 2000 Aug 01;56(2):216-22 PMID: 10925081 SCOPUS ID: 2-s2.0-0033915530 08/05/2000       14 Citations
  • Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. (Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, Cantor KP) Am J Epidemiol 2000 Feb 15;151(4):377-83 PMID: 10695596 SCOPUS ID: 2-s2.0-0034651505 03/01/2000       78 Citations
  • Distal ureteral regeneration after radical transurethral bladder tumor resection. (See WA) Urology 2000 Feb;55(2):212-5; discussion 215-6 PMID: 10688081 SCOPUS ID: 2-s2.0-0033967407 02/25/2000       13 Citations
  • Phase II trial of suramin in patients with metastatic renal cell carcinoma. (Dreicer R, Smith DC, Williams RD, See WA) Invest New Drugs 1999;17(2):183-6 PMID: 10638490 SCOPUS ID: 2-s2.0-0032785794 01/19/2000       27 Citations
  • Laparoscopic practice patterns among North American urologists 5 years after formal training. (Colegrove PM, Winfield HN, Donovan JF Jr, See WA) J Urol 1999 Mar;161(3):881-6 PMID: 10022705 SCOPUS ID: 2-s2.0-0032828255 02/18/1999       81 Citations
  • Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. (See WA) J Natl Cancer Inst 1998 Sep 02;90(17):1303 PMID: 9731738 SCOPUS ID: 2-s2.0-0032475446 09/10/1998    
  • Stable overexpression of TGFbeta1 in a transitional carcinoma cell line: impact on fibronectin production. (Zhang GJ, Ladehoff D, Xu Y, See WA) J Urol 1998 Jul;160(1):230-5 PMID: 9628655 SCOPUS ID: 2-s2.0-0032219219 06/17/1998       8 Citations
  • Pledgeted sutures for parenchymal compression facilitate partial nephrectomy. (Mulholland TL, See WA) Br J Urol 1998 Apr;81(4):630-3 PMID: 9598643 SCOPUS ID: 2-s2.0-0031868170 05/23/1998       6 Citations
  • Alterations in constituent urinary proteins in response to bladder outlet obstruction in rats. (Burns JA, Kreder KJ, Lubaroff DM, See WA) J Urol 1998 May;159(5):1747-51 PMID: 9554405 SCOPUS ID: 2-s2.0-0032467796 04/29/1998       3 Citations
  • Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: a 20-year followup. (Porter MP, Ahaghotu CA, Loening SA, See WA) J Urol 1997 Oct;158(4):1466-9 PMID: 9302144 SCOPUS ID: 2-s2.0-0030880621 09/25/1997       17 Citations
  • Future therapies for the treatment of bladder neoplasms. (See WA, Berman CJ) Semin Surg Oncol 1997;13(5):376-88 PMID: 9259094 SCOPUS ID: 2-s2.0-0030846549 09/01/1997       1 Citation
  • Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. (Griebling TL, Ozkutlu D, See WA, Cohen MB) Mod Pathol 1997 Aug;10(8):804-9 PMID: 9267823 SCOPUS ID: 2-s2.0-0030773267 08/01/1997       55 Citations
  • Continuous infusion, intravesical doxorubicin for the treatment of regionally advanced bladder cancer: a phase I-II trial. (See WA, Dreicer R, Forest PK, Riggs C) Am J Clin Oncol 1997 Aug;20(4):331-7 PMID: 9256884 SCOPUS ID: 2-s2.0-0030872570 08/01/1997       4 Citations
  • Surgical resection of metastatic renal cell carcinoma: The University of Iowa experience. (Dreicer R, Galbraith SS, Davis CS, See WA) Urol Oncol 1997;3(3):99-101 PMID: 21227093 05/01/1997    
  • Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines. (See WA, Xu Y, Gee K, Severson C, Cohen MB, Ladehoff D) J Urol 1997 Mar;157(3):1136-43 PMID: 9072558 SCOPUS ID: 2-s2.0-0031023234 03/01/1997       9 Citations
  • Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate. (Lund GO, Winfield HN, Donovan JF, See WA, Loening SA, Williams RD) J Urol 1997 Feb;157(2):548-51 PMID: 8996353 SCOPUS ID: 2-s2.0-0031033709 02/01/1997       8 Citations
  • Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. (Habboub HK, Abu-Yousef MM, Williams RD, See WA, Schweiger GD) AJR Am J Roentgenol 1997 Jan;168(1):267-71 PMID: 8976958 SCOPUS ID: 2-s2.0-0031021901 01/01/1997       49 Citations
  • A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer. (Dreicer R, Kemp JD, Stegink LD, Cardillo T, Davis CS, Forest PK, See WA) Cancer Invest 1997;15(4):311-7 PMID: 9246151 SCOPUS ID: 2-s2.0-0030797719 01/01/1997       22 Citations
  • Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy. (Dreicer R, Gustin DM, See WA, Williams RD) J Urol 1996 Nov;156(5):1606-8 PMID: 8863548 SCOPUS ID: 2-s2.0-0029853721 11/01/1996       100 Citations
  • Peritoneal venous shunting for the treatment of lymphatic ascites following retroperitoneal lymph node dissection. (See WA, Kresowik TF, Jochimsen PR) Urology 1996 Nov;48(5):783-5 PMID: 8911528 SCOPUS ID: 2-s2.0-0030298110 11/01/1996       6 Citations
  • Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial. (Sarosdy MF, Lowe BA, Schellhammer PF, Lamm DL, Graham SD Jr, Grossman HB, See WA, Peabody JO, Moon TD, Flanigan RC, Crawford ED, Morganroth J) Urology 1996 Jul;48(1):21-7 PMID: 8693646 SCOPUS ID: 2-s2.0-0343377307 07/01/1996       42 Citations
  • Brachytherapy and continuous infusion 5-fluorouracil for treatment of locally advanced, lymph node negative, prostate cancer: a phase I trial. (See WA, Dreicer R, Wheeler JA, Forest PK, Loening S) Cancer 1996 Mar 01;77(5):924-7 PMID: 8608485 SCOPUS ID: 2-s2.0-0030047318 03/01/1996       5 Citations
  • Incidence and management of testicular carcinoma metastatic to the neck. (See WA, Laurenzo JF, Dreicer R, Hoffman HT) J Urol 1996 Feb;155(2):590-2 PMID: 8558666 SCOPUS ID: 2-s2.0-0030024929 02/01/1996       41 Citations
  • Radical cystectomy--cornerstone or millstone? (See WA) J Urol 1996 Feb;155(2):504-5 PMID: 8558646 SCOPUS ID: 2-s2.0-0030076548 02/01/1996       2 Citations
  • Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis. (Terrell RB, Cheville JC, See WA, Cohen MB) J Urol 1995 Oct;154(4):1342-7 PMID: 7544836 SCOPUS ID: 2-s2.0-0029118201 10/01/1995       32 Citations
  • Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines. (Lyon PB, See WA, Xu Y, Cohen MB) Prostate 1995 Oct;27(4):179-86 PMID: 7479384 SCOPUS ID: 2-s2.0-0028802450 10/01/1995       29 Citations
  • An outcome study of patient-controlled morphine analgesia, with or without ketorolac, following radical retropubic prostatectomy. (See WA, Fuller JR, Toner ML) J Urol 1995 Oct;154(4):1429-32 PMID: 7658550 SCOPUS ID: 2-s2.0-0029118209 10/01/1995       25 Citations
  • Council-tip catheter facilitates vesicourethral anastomotic suture placement. (See WA) Urology 1995 Sep;46(3):401-2 PMID: 7660518 SCOPUS ID: 2-s2.0-0028800251 09/01/1995       8 Citations
  • Commentary on growth factors: the bread-and-butter cytokines of urology. (See WA) J Urol 1994 Dec;152(6 Pt 1):1942 PMID: 7966647 SCOPUS ID: 2-s2.0-0028072347 12/01/1994       4 Citations
  • Laparoscopy at the crossroads. (See WA) J Urol 1994 Oct;152(4):1193 PMID: 8072093 SCOPUS ID: 2-s2.0-0028085837 10/01/1994       7 Citations
  • Regulation of plasminogen activator activity in transitional carcinoma cell lines by wound site growth factors. (Xu Y, See WA) Surg Oncol 1994 Jun;3(3):175-85 PMID: 7952402 SCOPUS ID: 2-s2.0-0027984942 06/01/1994       3 Citations
  • Diversity and modulation of plasminogen activator activity in human transitional carcinoma cell lines. (See WA, Yong X, Crist S, Hedican S) J Urol 1994 Jun;151(6):1691-6 PMID: 8189598 SCOPUS ID: 2-s2.0-0028279445 06/01/1994       6 Citations
  • Urological laparoscopic practice patterns 1 year after formal training. (See WA, Cooper CS, Fisher RJ) J Urol 1994 Jun;151(6):1595-8 PMID: 8189571 SCOPUS ID: 2-s2.0-0028285417 06/01/1994       22 Citations
  • Predictors of laparoscopic complications after formal training in laparoscopic surgery. (See WA, Cooper CS, Fisher RJ) JAMA 1993 Dec 08;270(22):2689-92 PMID: 8133586 SCOPUS ID: 2-s2.0-0027495556 12/08/1993       207 Citations
  • Chest staging in testis cancer patients: imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results. (See WA, Hoxie L) J Urol 1993 Sep;150(3):874-8 PMID: 8345604 SCOPUS ID: 2-s2.0-0027204161 09/01/1993       43 Citations
  • Plasminogen activators: regulators of tumor cell adherence to sites of lower urinary tract surgical trauma. (See WA) J Urol 1993 Sep;150(3):1024-9 PMID: 8345579 SCOPUS ID: 2-s2.0-0027214415 09/01/1993       8 Citations
  • Laparoscopic surgical training: effectiveness and impact on urological surgical practice patterns. (See WA, Fisher RJ, Winfield HN, Donovan JF) J Urol 1993 May;149(5):1054-7 PMID: 8483208 SCOPUS ID: 2-s2.0-0027221563 05/01/1993       36 Citations
  • Inverted V peritoneotomy significantly improves nodal yield in laparoscopic pelvic lymphadenectomy. (See WA, Cohen MB, Winfield HN) J Urol 1993 Apr;149(4):772-5 PMID: 8455241 SCOPUS ID: 2-s2.0-0027415257 04/01/1993       16 Citations
  • Alpha-fetoprotein half-life as a predictor of residual testicular tumor. Effect of the analytic strategy on test sensitivity and specificity. (See WA, Cohen MB, Hoxie LD) Cancer 1993 Mar 15;71(6):2048-54 PMID: 7680279 SCOPUS ID: 2-s2.0-0027405056 03/15/1993       13 Citations
  • Granulomatous inflammation in bladder wash specimens after intravesical bacillus Calmette-Guerin therapy for transitional cell carcinoma of the bladder. (Betz SA, See WA, Cohen MB) Am J Clin Pathol 1993 Mar;99(3):244-8 PMID: 8447285 SCOPUS ID: 2-s2.0-0027456858 03/01/1993       26 Citations
  • Staging of advanced bladder cancer. Current concepts and pitfalls. (See WA, Fuller JR) Urol Clin North Am 1992 Nov;19(4):663-83 PMID: 1441024 SCOPUS ID: 2-s2.0-0026808568 11/01/1992       43 Citations
  • The impact of iatrogenic urothelial trauma on urinary levels of transforming growth factor-alpha. (Cooper CS, See WA) J Urol 1992 Jun;147(6):1647-9 PMID: 1593715 SCOPUS ID: 2-s2.0-0026682644 06/01/1992       17 Citations
  • In vitro particulate adherence to fibronectin: correlation with in vivo particulate adherence to sites of bladder injury. (See WA, Rohlf DP, Crist SA) J Urol 1992 May;147(5):1416-23 PMID: 1569698 SCOPUS ID: 2-s2.0-0026687416 05/01/1992       16 Citations
  • Tumors of the kidney, ureter, and bladder. (See WA, Williams RD) West J Med 1992 May;156(5):523-34 PMID: 1595278 PMCID: PMC1003316 SCOPUS ID: 2-s2.0-0026591016 05/01/1992       4 Citations
  • Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. (See WA, Xia Q) J Natl Cancer Inst 1992 Apr 01;84(7):510-5 PMID: 1545441 SCOPUS ID: 2-s2.0-0026559523 04/01/1992       32 Citations
  • Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces. (See WA, Williams RD) J Urol 1992 Mar;147(3):541-8 PMID: 1538425 SCOPUS ID: 2-s2.0-0026569036 03/01/1992       39 Citations
  • Intravesical recombinant tissue plasminogen activator for the prevention of implantation-mediated bladder tumor recurrence. (See WA) Clin Exp Metastasis 1992 Mar;10(2):99-109 PMID: 1537139 SCOPUS ID: 2-s2.0-0026595673 03/01/1992       6 Citations
  • Urinary trypsin levels observed in pancreas transplant patients with duodenocystostomies promote in vitro fibrinolysis and in vivo bacterial adherence to urothelial surfaces. (See WA, Smith JL) Urol Res 1992;20(6):409-13 PMID: 1462479 SCOPUS ID: 2-s2.0-0026447942 01/01/1992       9 Citations
  • Intracorporeal needle breakage: an unusual complication of papaverine injection therapy for impotence. (Beer SJ, See WA) J Urol 1992 Jan;147(1):148-50 PMID: 1729511 SCOPUS ID: 2-s2.0-0026527087 01/01/1992       14 Citations
  • Antimicrobial tissue penetration in a rat model of E. coli epididymitis. (Tartaglione TA, Taylor TO, Opheim KE, See WA, Berger RE) J Urol 1991 Nov;146(5):1413-7 PMID: 1942312 SCOPUS ID: 2-s2.0-0026334725 11/01/1991       8 Citations
  • Urological laparoscopic surgery. (Winfield HN, Donovan JF, See WA, Loening SA, Williams RD) J Urol 1991 Oct;146(4):941-8 PMID: 1680202 SCOPUS ID: 2-s2.0-0026096181 10/01/1991       153 Citations
  • Urinary levels of activated trypsin in whole-organ pancreas transplant patients with duodenocystostomies. (See WA, Smith JL) Transplantation 1991 Oct;52(4):630-3 PMID: 1926341 SCOPUS ID: 2-s2.0-0025989944 10/01/1991       49 Citations
  • Regional chemotherapy using continuous intravesical infusion doxorubicin for the treatment of muscle invasive transitional cell bladder carcinoma in a rat model. (See WA, Xia Q, McDermott T, Williams RD) J Urol 1991 Oct;146(4):1147-52 PMID: 1895443 SCOPUS ID: 2-s2.0-0026002160 10/01/1991       3 Citations
  • Ectopic ureter: a rare cause of purulent vaginal discharge. (See WA, Mayo M) Obstet Gynecol 1991 Sep;78(3 Pt 2):552-5 PMID: 1870821 SCOPUS ID: 2-s2.0-0025912041 09/01/1991       9 Citations
  • A continuous intravesical drug delivery system for the rat. (See WA, McDermott T, Xia Q, Williams RD) J Urol 1991 Mar;145(3):596-9 PMID: 1997716 SCOPUS ID: 2-s2.0-0025859259 03/01/1991       5 Citations
  • Single-dose cyclophosphamide for the prevention of bladder tumor implantation in F344 rats: site of drug activity. (See WA, Crist SA, Williams RD) Cancer Res 1991 Mar 01;51(5):1378-83 PMID: 1997176 SCOPUS ID: 2-s2.0-0025728826 03/01/1991       1 Citation
  • Single-dose preoperative systemic cyclophosphamide for the prevention of bladder tumor implantation in F344 rats. (See WA, Crist SA, Boileau MA, Williams RD) Cancer Res 1991 Mar 01;51(5):1373-7 PMID: 1997175 SCOPUS ID: 2-s2.0-0025804902 03/01/1991       2 Citations
  • Activated proteolytic enzymes in the urine of whole organ pancreas transplant patients with duodenocystostomy. (See WA, Smith JL) Transplant Proc 1991 Feb;23(1 Pt 2):1615-6 PMID: 1989308 SCOPUS ID: 2-s2.0-0026019848 02/01/1991       15 Citations
  • Lower urinary tract complications in patients with duodenocystostomies for exocrine drainage of the transplanted pancreas. (Smith JL, See WA, Ames SA, Piper JB, Corry RJ) Transplant Proc 1991 Feb;23(1 Pt 2):1611-2 PMID: 1989307 SCOPUS ID: 2-s2.0-0026034339 02/01/1991       23 Citations
  • Bacterial epididymitis in the rat: a model for assessing the impact of acute inflammation on epididymal antibiotic penetration. (See WA, Taylor TO, Mack LA, Tartaglione TA, Opheim KE, Berger RE) J Urol 1990 Sep;144(3):780-4 PMID: 2201798 SCOPUS ID: 2-s2.0-0025024411 09/01/1990       15 Citations
  • Kinetics of transitional tumor cell line 4909 adherence to injured urothelial surfaces in F-344 rats. (See WA, Chapman PH, Williams RD) Cancer Res 1990 Apr 15;50(8):2499-504 PMID: 2317832 SCOPUS ID: 2-s2.0-0025231302 04/15/1990       14 Citations
  • Pathophysiology of transitional tumor cell adherence to sites of urothelial injury in rats: mechanisms mediating intravesical recurrence due to implantation. (See WA, Miller JS, Williams RD) Cancer Res 1989 Oct 01;49(19):5414-8 PMID: 2766306 SCOPUS ID: 2-s2.0-0024466426 10/01/1989       40 Citations
  • Scrotal ultrasonography: a predictor of complicated epididymitis requiring orchiectomy. (See WA, Mack LA, Krieger JN) J Urol 1988 Jan;139(1):55-6 PMID: 3275802 SCOPUS ID: 2-s2.0-0023911090 01/01/1988       18 Citations
  • Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces. (See WA, Chapman PH) J Urol 1987 Jul;138(1):182-6 PMID: 2955131 SCOPUS ID: 2-s2.0-0023225036 07/01/1987       43 Citations
  • Tumor cell implantation following neodymium-YAG bladder injury: a comparison to electrocautery injury. (See WA, Chapman WH) J Urol 1987 Jun;137(6):1266-9 PMID: 3586172 SCOPUS ID: 2-s2.0-0023204574 06/01/1987       51 Citations
    • Last update: 07/26/2016